{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:35:11Z","timestamp":1779885311533,"version":"3.53.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1743-422x-8-248","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T02:15:17Z","timestamp":1305944117000},"source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of Hepatitis C Virus 3a genotype entry through Glanthus Nivalis Agglutinin"],"prefix":"10.1186","volume":"8","author":[{"given":"Usman A","family":"Ashfaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad S","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Riazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"1351_CR1","first-page":"4","volume":"41","author":"NS Raja","year":"2008","unstructured":"Raja NS, Janjua NK: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. J Microbiol Immunol Infect 2008, 41: 4-8.","journal-title":"J Microbiol Immunol Infect"},{"key":"1351_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0168-8278(01)00179-9","volume":"35","author":"M Berenguer","year":"2001","unstructured":"Berenguer M, Lopez-Labrador FX, Wright TL: Hepatitis C and liver transplantation. J Hepatol 2001, 35: 666-678. 10.1016\/S0168-8278(01)00179-9","journal-title":"J Hepatol"},{"key":"1351_CR3","volume-title":"Department of Measurement and Health Information","author":"WHO: World Health Organization","year":"2004","unstructured":"WHO: World Health Organization: Department of Measurement and Health Information.2004. [\n                    http:\/\/www.who.int\/healthinfo\/statistics\/bodgbddeathdalyestimates.xls\n                    \n                  ]"},{"key":"1351_CR4","first-page":"S3","volume":"36","author":"KM Scannell","year":"2002","unstructured":"Scannell KM, Willard CC, Seeff LB: National Institutes of Health Consensus Development Conference Statement: management of hepatitis C. Hepatology 2002, 36: S3-S20.","journal-title":"Hepatology"},{"key":"1351_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00268-007-9041-3","volume":"31","author":"Y Barazani","year":"2007","unstructured":"Barazani Y, Hiatt JR, Tong MJ, Busuttil RW: Chronic viral hepatitis and hepatocellular carcinoma. World J Surg 2007, 31: 1243-1248.","journal-title":"World J Surg"},{"key":"1351_CR6","first-page":"642","volume":"39","author":"NH Saleem","year":"2008","unstructured":"Saleem NH, Adrien A, Razaque A: Risky sexual behavior, knowledge of sexually transmitted infections and treatment utilization among a vulnerable population in Rawalpindi, Pakistan. Southeast Asian J Trop Med Public Health 2008, 39: 642-648.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"1351_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2893.2006.00742.x","volume":"13","author":"M Karmochkine","year":"2006","unstructured":"Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G: A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 2006, 13: 775-782. 10.1111\/j.1365-2893.2006.00742.x","journal-title":"J Viral Hepat"},{"key":"1351_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","volume":"546","author":"HE Drummer","year":"2003","unstructured":"Drummer HE, Maerz A, Poumbourios P: Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 2003, 546: 385-390. 10.1016\/S0014-5793(03)00635-5","journal-title":"FEBS Lett"},{"key":"1351_CR9","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","volume":"79","author":"A Goffard","year":"2005","unstructured":"Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J: Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 2005, 79: 8400-8409. 10.1128\/JVI.79.13.8400-8409.2005","journal-title":"J Virol"},{"key":"1351_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2003.10.008","volume":"319","author":"T Slater-Handshy","year":"2004","unstructured":"Slater-Handshy T, Droll DA, Fan X, Di Bisceglie AM, Chambers TJ: HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Virology 2004, 319: 36-48. 10.1016\/j.virol.2003.10.008","journal-title":"Virology"},{"key":"1351_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0014-5793(87)80129-1","volume":"215","author":"EJM Van Damme","year":"1987","unstructured":"Van Damme EJM, Allen AK, Peumans WJ: Isolation and characterization of lectin with exclusive specificity towards mannose from snowdrop (Galanthus nivalis) bulbs. FEBS Lett 1987, 215: 140-144. 10.1016\/0014-5793(87)80129-1","journal-title":"FEBS Lett"},{"key":"1351_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1128\/AAC.35.3.410","volume":"35","author":"J Balzarini","year":"1991","unstructured":"Balzarini J, Schols D, Neyts J, Van Damme E, Peumans W, De Clercq E: Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro. Antimicrob Agents Chemother 1991, 35: 410-416.","journal-title":"Antimicrob Agents Chemother"},{"key":"1351_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-3542(92)90038-7","volume":"18","author":"J Balzarini","year":"1992","unstructured":"Balzarini J, Neyts J, Schols D, Hosoya M, Van Damme E, Peumans W, De Clercq E: The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res 1992, 18: 191-207. 10.1016\/0166-3542(92)90038-7","journal-title":"Antiviral Res"},{"key":"1351_CR14","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1128\/AAC.48.10.3858-3870.2004","volume":"48","author":"J Balzarini","year":"2004","unstructured":"Balzarini J, Hatse S, Vermeire K, Princen K, Aquaro S, Perno CF, De Clercq E, Egberink H, Vanden Mooter G, Peumans W, et al.: Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrob Agents Chemother 2004, 48: 3858-3870. 10.1128\/AAC.48.10.3858-3870.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"1351_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","volume":"6","author":"T Lengauer","year":"1996","unstructured":"Lengauer T, Rarey M: Computational methods for biomolecular docking. Curr Opin Struct Biol 1996, 6: 402-406. 10.1016\/S0959-440X(96)80061-3","journal-title":"Curr Opin Struct Biol"},{"key":"1351_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","volume":"197","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Dubuisson J, Cosset FL: Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003, 197: 633-642. 10.1084\/jem.20021756","journal-title":"J Exp Med"},{"key":"1351_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55-63. 10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"key":"1351_CR18","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0832180100","volume":"100","author":"M Hsu","year":"2003","unstructured":"Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA: Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003, 100: 7271-7276. 10.1073\/pnas.0832180100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1351_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.biolcel.2004.03.008","volume":"96","author":"C Voisset","year":"2004","unstructured":"Voisset C, Dubuisson J: Functional hepatitis C virus envelope glycoproteins. Biol Cell 2004, 96: 413-420. 10.1016\/j.biolcel.2004.03.008","journal-title":"Biol Cell"},{"issue":"Pt 4","key":"1351_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1099\/0022-1317-80-4-887","volume":"80","author":"JC Meunier","year":"1999","unstructured":"Meunier JC, Fournillier A, Choukhi A, Cahour A, Cocquerel L, Dubuisson J, Wychowski C: Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J Gen Virol 1999,80(Pt 4):887-896.","journal-title":"J Gen Virol"},{"key":"1351_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(07)60202-5","volume":"369","author":"J Balzarini","year":"2007","unstructured":"Balzarini J, Van Damme L: Microbicide drug candidates to prevent HIV infection. Lancet 2007, 369: 787-797. 10.1016\/S0140-6736(07)60202-5","journal-title":"Lancet"},{"key":"1351_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.virol.2007.08.033","volume":"370","author":"M Pollicita","year":"2008","unstructured":"Pollicita M, Schols D, Aquaro S, Peumans WJ, Van Damme EJ, Perno CF, Balzarini J: Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. Virology 2008, 370: 382-391. 10.1016\/j.virol.2007.08.033","journal-title":"Virology"},{"key":"1351_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1124\/mol.108.047621","volume":"74","author":"KO Francois","year":"2008","unstructured":"Francois KO, Auwerx J, Schols D, Balzarini J: Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. Mol Pharmacol 2008, 74: 330-337. 10.1124\/mol.108.047621","journal-title":"Mol Pharmacol"},{"key":"1351_CR24","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1128\/JVI.79.12.7777-7784.2005","volume":"79","author":"M Witvrouw","year":"2005","unstructured":"Witvrouw M, Fikkert V, Hantson A, Pannecouque C, O'Keefe B R, McMahon J, Stamatatos L, de Clercq E, Bolmstedt A: Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J Virol 2005, 79: 7777-7784. 10.1128\/JVI.79.12.7777-7784.2005","journal-title":"J Virol"},{"key":"1351_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0300-9084(03)00004-X","volume":"85","author":"A Goffard","year":"2003","unstructured":"Goffard A, Dubuisson J: Glycosylation of hepatitis C virus envelope proteins. Biochimie 2003, 85: 295-301. 10.1016\/S0300-9084(03)00004-X","journal-title":"Biochimie"},{"key":"1351_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nature04080","volume":"436","author":"R De Francesco","year":"2005","unstructured":"De Francesco R, Migliaccio G: Challenges and successes in developing new therapies for hepatitis C. Nature 2005, 436: 953-960. 10.1038\/nature04080","journal-title":"Nature"},{"key":"1351_CR27","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1002\/hep.21064","volume":"43","author":"JM Pawlotsky","year":"2006","unstructured":"Pawlotsky JM: Therapy of hepatitis C: from empiricism to eradication. Hepatology 2006, 43: S207-220. 10.1002\/hep.21064","journal-title":"Hepatology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-8-248\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T16:30:17Z","timestamp":1548174617000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-248","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]},"article-number":"248"}}